ENO2 and carcinoma: Generally, this NE phenotype is positive for markers of other high-grade NE carcinomas, such as chromogranin A(CHGA), neuron-specific enolase (NSE), synaptophysin (SYP), and CD56, and negative for luminal prostate differentiation markers (4).